We are live on
!
Find out more
EC
Eminence Capital Portfolio holdings
AUM
$4.36B
1-Year Est. Return
3.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.26%
1 Year Est. Return
-3.1%
3 Year Est. Return
+37.18%
5 Year Est. Return
+35.48%
10 Year Est. Return
+262.43%
AUM
$8.89B
AUM Growth
+$585M
(+7%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
38.11%
Holding
69
New
12
Increased
12
Reduced
34
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$175M |
| 2 |
NEWR
New Relic, Inc.
NEWR
|
+$164M |
| 3 |
Uber
UBER
|
+$133M |
| 4 |
US Foods
USFD
|
+$108M |
| 5 |
Corteva
CTVA
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$138M |
| 2 |
American Express
AXP
|
+$125M |
| 3 |
Sysco
SYY
|
+$103M |
| 4 |
Royal Caribbean
RCL
|
+$85.5M |
| 5 |
PG&E
PCG
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.82% |
| 2 | Materials | 17.16% |
| 3 | Communication Services | 15.21% |
| 4 | Financials | 13.25% |
| 5 | Technology | 11.83% |
Similar funds
SFM
EQF
B
NHC
NEI
FIS
CFO
Eminence Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Eminence Capital held 69 positions worth $8.89B, up 7% from $8.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Eminence Capital's Q4 2019 filing shows 12 new, 12 increased, 34 reduced and 11 closed positions. Its largest new stake was Progressive: 2,420,808 shares worth $175M. The largest sale was Thermo Fisher Scientific, an estimated $138M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 22% a quarter earlier, followed by Materials and Communication Services.
- Eminence Capital's largest Q4 2019 buy was Progressive: 2,420,808 shares worth $175M.
- Eminence Capital added most to US Foods in Q4 2019, an estimated $108M increase.
- Eminence Capital's biggest Q4 2019 reduction was Royal Caribbean, cutting an estimated $85.5M.
- Eminence Capital fully exited Thermo Fisher Scientific in Q4 2019, selling an estimated $138M.
- Eminence Capital's ten largest holdings make up 38% of its $8.89B portfolio in Q4 2019.
- Eminence Capital opened 12 new positions and closed 11 in Q4 2019.
- Eminence Capital's portfolio value rose 7% quarter-over-quarter to $8.89B.
Based on Eminence Capital's 13F filing for Q4 2019, filed 14 Feb 2020.